Details for 2023730718
Up to date per 02.04.2026
Actions
Details for 2023730718
Granted/Registered
European Patent
18.09.2024 A
26.02.2025 B1
18.05.2022
GB
202207263
A61K 38/17 20060101AFI20231201BHEP
Owner
Annexin Pharmaceuticals ABKammakargatan 48 111 60 StockholmSE
Representative
No representatives present
Inventor
FROSTEGÅRD, Anna 11160 StockholmSE
HAEGERSTRAND, Anders 11160 StockholmSE
Information about Fees